Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Phospho-TFE3 (Ser321) (F1E8R) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-TFEB (Ser122) (E9M5M) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-ULK1 (Ser317) (F1Z6C) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-ULK1 (Thr180) (E4N8N) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-VASP (Ser239) (E9L7Y) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-YAP (Ser61) (E4Q8S) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-α-Adducin (Ser12) (E5X8Y) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-β-Dystroglycan (Tyr892) (E6T9O) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

PHOX2B (E4Q9R) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

PI3 Kinase p110 δ (E2T2N) Rabbit mAb


Cell Signalling Technology logo
View Antibody details